Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 804 results for "daiichi sankyo company"

Daiichi Sankyo receives FDA approval for venous thromboembolis...

Daiichi Sankyo Company, Limited has received the FDA approval for SAVAYSA tablets, an oral, once-daily selective factor Xa-inhibitor, for reduction of stroke risk in non-valvular atrial fibrillation, or NVAF, and for the treatment of venous ... Individual.com, 1 week ago
New and Generic Drug Approvals: Savaysa U.S. Food and Drug Administration, 2 weeks ago
[x]  
Pharmafocus

Daiichi Sankyo to Pay Justice Department $39 Million Over Kickback Claims

Daiichi Sankyo will pay the federal government $39 million to resolve allegations it used lavish dinners and other kickbacks to persuade physicians to prescribe more of the company's drugs. A whistleblower lawsuit filed by a former Daiichi Sankyo ...
 FDA News1 week ago DAIICHI SANKYO : Announces Civil Settlement  4 Traders1 week ago Daiichi-Sankyo pays $39m to settle allegations  Pharmafocus2 weeks ago New Jersey Pharmaceutical Company Agrees to Pay $39 Million to Settle Alleged Anti-Kickback Violations  National Law Review1 week ago
[x]  

Daiichi Sankyo launches new formulation of anti-thrombotic drug in Japan

Daiichi Sankyo Company, Limited has launched a new formulation of LIXIANA 60mg Tablets, or edoxaban, in Japan for the recently approved indications of the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial ...
 Individual.com1 month ago DAIICHI SANKYO : American Regent's Injectafer┬« ferric carboxymaltose injection Assigned J Code by Centers for Medicare & Medicaid Services  4 Traders1 month ago DAIICHI SANKYO : Launches New Formulation of LIXIANA┬« 60 mg Tablets edoxaban in Japan  4 Traders1 month ago

Daiichi Sankyo Espha launches nine new generic drugs

(MarketLine via COMTEX News Network) -- Daiichi Sankyo Company, Limited has announced that its generics subsidiary, Daiichi Sankyo Espha, has launched Levofloxacin Tablets DSEP 250mg, 500mg and Granules 10% whose therapeutic category is ...
 PredictWallStreet3 weeks ago

Daiichi Sankyo Company, Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its ...
 MarketResearch.com1 month ago

Nolan Auerbach & White Resolves Daiichi Sankyo Whistleblower Case

Nolan Auerbach & White reported the successful resolution of its client's five-year-long civil False Claims Act case against Daiichi Sankyo. According to a company release, the qui tam case was brought in March 2010 by client Kathy Fragoules, a ...
 Individual.com1 week ago DAIICHI SANKYO : Nolan Auerbach & White Resolves Daiichi Sankyo Whistleblower Case  4 Traders1 week ago Daiichi Sankyo Whistleblower Case Returns Over $39 Million to the Government  Yahoo! Finance2 weeks ago

Fortis HealthWorld Acquires Pharma Retail Chain CRS Health

This is the first acquisition of the Singh brothers after they sold Ranbaxy to Daiichi Sankyo. Ranbaxy Group promoted Fortis Healthworld has acquired 90 percent stake in CRS Health, a Delhi-based pharma and wellness retail chain for Rs 15 crore, ...
 VC Circle1 month ago

DAIICHI SANKYO : Patent Application Titled "Tablet, Method of Producing Tablet, Tablet Management Device, Tablet Verification Device and Program Storage Medium"...

Patent Application Titled "Tablet, Method of Producing Tablet, Tablet Management Device, Tablet Verification Device and Program Storage Medium" Published Online By a News Reporter-Staff News Editor at Politics & Government Week -- According to ...
 4 Traders2 days ago

DAIICHI SANKYO : Patent Issued for Method for Producing Olmesartan Medoxomil

By a News Reporter-Staff News Editor at Pharma Business Week -- A patent by the inventor Yanagihara, Shigeo ( Tokyo , JP), filed on April 27, 2010 , was published online on January 13, 2015 , according to news reporting originating from Alexandria, ...
 4 Traders2 days ago Patent Issued for Crystals of Substituted Cycloalkene Derivatives  4 Traders2 days ago

DAIICHI SANKYO : Plexxikon and QuantumLeap Healthcare Collaborative Select PLX3397 for I-SPY 2 Trial in Breast Cancer

Plexxikon and QuantumLeap Healthcare Collaborative said that Plexxikon's drug candidate, PLX3397, has been selected for study in the I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular ...
 4 Traders1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less